Date | Source | Headline | |
---|---|---|---|
30th Apr 2024 | 6:19 pm | RNS | Annual results |
25th Jan 2024 | 7:30 am | RNS | Restoration - Ashington Innovation PLC |
24th Jan 2024 | 7:00 am | RNS | Termination of Proposed Reverse Takeover |
12th Jan 2024 | 12:30 pm | RNS | Results of Annual General Meeting |
20th Dec 2023 | 2:00 pm | RNS | Posting of Annual Report and Notice of AGM |
20th Dec 2023 | 1:15 pm | RNS | Issue of Equity |
20th Dec 2023 | 7:00 am | RNS | Appointment of New Auditors |
8th Nov 2023 | 3:30 pm | RNS | Board changes |
16th Oct 2023 | 7:00 am | RNS | Appointment of Non-Executive Director |
5th Sep 2023 | 7:00 am | RNS | Update on Cell Therapy and Calon Discussions |
24th Aug 2023 | 7:00 am | RNS | Heads of Terms Signed for the Acquisition of Calon |
21st Aug 2023 | 7:00 am | RNS | Dual Listing on the Frankfurt Stock Exchange |
17th Aug 2023 | 8:10 am | RNS | Heads of Terms Signed |
17th Aug 2023 | 7:30 am | RNS | Suspension - Ashington Innovation PLC |
16th Aug 2023 | 7:00 am | RNS | Board Change |
9th Aug 2023 | 12:26 pm | RNS | Change of Accounting Reference Date |
6th Jun 2023 | 8:01 am | RNS | Ashington - Admission to trading on the LSE |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.